Incyte News and Activities

Presence

Incyte is a biopharmaceutical company that primarily focuses on the discovery, development, and commercialization of proprietary therapeutics for oncology and other serious diseases. Their products are designed for medical professionals and patients in need of novel treatments.

Incyte products and services overview:

Hematology/Oncology
Inflammation and Autoimmunity

2024 Revenue: Approximately $3 billion

Employees: 1,700

Incyte is one of the...

Incyte is a company listed under the stock ticker INCY (US).

Incyte has a direct presence in 3 countries.

They are in:

Biotechnology67%
Pharmaceuticals33%

Acquisition, funding and merger involving Incyte.

Vor Biopharma and Incyte have announced they will merge (posted on June 30 2025)..

Executives

View the org chart displaying its 47 main executives

Most searched biographies at Incyte

Popular executive movements at Incyte

Bill Meury has joined the company as President and Chief Executive Officer (posted on June 27 2025).
Julian Baker, who was Director, is promoted to Chairman of the Board (posted on June 27 2025).

Create your alert
to follow the executive moves at Incyte.